11 Best GLP-1 and Weight Loss Stocks to Invest in

8. AstraZeneca PLC (NASDAQ:AZN)

Number of Hedge Fund Holders: 56

AstraZeneca PLC (NASDAQ:AZN) and Revna Biosciences have succeeded in expanding access to EGFR-targeted lung cancer medication in Ghana, achieving a significant milestone since their collaboration began in April 2025. AstraZeneca PLC (NASDAQ:AZN)’s targeted therapy for patients with EGFR-mutated lung cancer marks an improvement in access to treatment in sub-Saharan Africa.

The partnership made it possible for leading cancer centers to incorporate EGFR biomarker testing into their diagnostic processes, which helped them make more accurate treatment choices. Revna organized a training workshop and strategic symposium to improve clinical processes and diagnostic skills. Future research and clinical decision-making are supported by real-time data integration.

AstraZeneca PLC (NASDAQ:AZN)’s Dr. Khomotso Mashilane noted the significance of merging diagnostics with targeted treatments. Revna CEO Dr. Derrick Edem Akpalu addressed the ecosystem’s importance in removing access obstacles. Dr. Preetivi Ellis, a co-founder, stressed how the work is transforming treatment for patients today and developing the genomic foundation for care in the future. It is one of the Best Weight Loss Stocks.